| ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma. |
2022 |
Megino Luque, C.; Sisó, P.; Mota Martorell, N.; Navaridas, R.; de la Rosa, I.; Urdanibia, I.; Albertí Valls, M.; Santacana, M.; Pinyol, M.; Bonifaci, N.; Macià, A.; Llobet Navas, D.; Gatius, S.; Matia |
Article d'investigació |
| Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition |
2022 |
Ruiz Mitjana, A.; Navaridas, R.; Vidal Sabanés, M.; Perramon Güell, A.; Yeramian, A.; Felip, I.; Eritja, N.; Egea, J.; Encinas, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| M-CSF as a therapeutic target in BRAF V600E melanoma resistant to BRAF inhibitors |
2022 |
Barceló, C.; Sisó, P.; de la Rosa, I.; Megino Luque, C.; Navaridas, R.; Maiques, O.; Urdanibia, I.; Eritja, N.; Soria, X.; Potrony, M.; Calbet Llopart, N.; Puig, S.; Matías Guiu, X.; Martí, R.M.; Maci |
Article d'investigació |
| Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer |
2022 |
Gatius, S.; Jove, M.; Megino Luque, C.; Albertí Valls, M.; Yeramian, A.; Bonifaci, N.; Piñol, M.; Santacana, M.; Pradas, I.; Llobet Navas, D.; Pamplona, R.; Matías Guiu, X.; Eritja, N. |
Article d'investigació |
| Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation. |
2021 |
Eritja, N.; Navaridas, R.; Ruiz Mitjana, A.; Vidal Sabanés, M.; Egea, J.; Encinas, M, Matias Guiu, X.; Dolcet, X. |
Article en revista divulgativa |
| Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma. |
2021 |
Sanegre, S.; Eritja, N.; de Andrea, C.; Diaz Martin, J.; Diaz Lagares, Á.; Jácome, M.A.; Salguero Aranda, C.; García Ros, D.; Davidson, B.; Lopez, R.; Melero, I.; Navarro, S.; Ramon Y Cajal, S.; de Al |
Article d'investigació |
| T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF(V600E) melanoma |
2020 |
Barceló, C.; Sisó, P.; Maiques, O.; García-Mulero, S.; Sanz-Pamplona, R.; Navaridas, R.; Megino, C.; Felip, I.; Urdanibia, I.; Eritja, N.; Soria, X.; Piulats, J.M.; Penin, R.M.; Dolcet, X.; Matías-Gui |
Article d'investigació |
| Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer |
2020 |
Megino-Luque, C.; Moiola, C.P.; Molins-Escuder, C.; López-Gil, C.; Gil-Moreno, A.; Matias-Guiu, X.; Colas, E.; Eritja N. |
Article d'investigació |
| Autophagy in the physiological endometrium and cancer |
2020 |
Devis-Jauregui, L.; Eritja, N.; Davis, M.L.; Matias-Guiu, X.; Llobet-Navàs, D. |
Article d'investigació |
| Intratumor heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification (MLPA). A DESCRIPTIVE STUDY. |
2020 |
Cuevas D; Velasco A; Vaquero M; Santacana M; Gatius S; Eritja N; Estaran E; Matias-Guiu X. |
Article d'investigació |
| Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis. |
2019 |
Dosil MA, Navaridas R, Mirantes C, Tarragona J, Eritja N, Felip I, Urdanibia I, Megino C, Domingo M, Santacana M, Gatius S, Piñol C, Barceló C, Maiques O, Macià A, Velasco A, Vaquero M, Matias-Guiu X, |
Article d'investigació |
| Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer. |
2019 |
Felip I; Moiola CP; Megino-Luque C; Lopez-Gil C; Cabrera S; Solé-Sánchez S; Muñoz-Guardiola P; Megias-Roda E;Pérez-Montoyo H;Alfon J;Yeste-Velasco M; Santacana M; Dolcet X; Reques A; Oaknin A; Rodrígu |
Article d'investigació |
| Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma. |
2019 |
Cuevas D; Valls J; Gatius S: Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X. |
Article d'investigació |
| High-carotenoid maize: development of plant biotechnology prototypes for human and animal health and nutrition |
2018 |
Zhu C; Farre G; Zanga D; Lloveras J; Michelena A; Ferrio JP; Voltas J; Slafer GA; Savin R; Albajes R; Eizaguirre M; Lopez C; Cantero-Martínez C; Díaz-Gómez J; Nogareda C; Moreno JA; Angulo E; Estany J |
Review |
| A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium. |
2017 |
Eritja, N.; Felip, I.; Dosil, M.A.; Vigezzi, L.; Mirantes, C.; Yeramian, A.; Navaridas, R.; Santacana, M.; Llobet Navas, D.; Yoshimura, A.; Nomura, M.; Encinas, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias. |
2017 |
Dosil, MA; Mirantes, C; Eritja, N; Felip, I; Navaridas, R; Gatius, S; Santacana, M; Colàs, E; Moiola, C; Schoenenberger, JA; Encinas, M; Garí, E; Matias-Guiu, X; Dolcet, X. |
Article d'investigació |
| Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer |
2017 |
Eritja N; Chen BJ; Rodríguez-Barrueco R; Santacana M; Gatius S; Vidal A; Martí MD; Ponce J; Bergadà L; Yeramian A; Encinas M; Ribera J; Reventós J; Boyd J; Villanueva A; Matias-Guiu X; Dolcet X; Llobe |
Article d'investigació |
| Endometrial Carcinoma: Specific Targeted Pathways. |
2017 |
Eritja N; Yeramian A; Chen BJ; Llobet-Navas D; Ortega E; Colas E; Abal M; Dolcet X; Reventos J; Matias-Guiu X. |
Review |
| Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. |
2017 |
Eritja N; Jove M; Eldevik Fasmer K; Gatius S; Portero-Otin M; Trovik J; Krakstad C; Sol J; Pamplona R; Haldorsen IS; Matias-Guiu X. |
Article d'investigació |
| Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice. |
2016 |
Eritja N; Arjo G; Santacana M; Gatius S; Arcal L; Serrano JC; Pamplona R; Dolcet X; Piñol C; Christou P; Matias-Guiu X; Portero-Otin M. |
Article d'investigació |
| Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma, but not myeloid malignancies. |
2016 |
Mirantes C, Dosil MA, Hills D, Yang J, Eritja N, Santacana M, Gatius S, Vilardell F, Medvinsky A, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasias |
2016 |
Mirantes C, Dosil MA, Eritja N, Felip I, Gatius S, Santacana M, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism |
2016 |
Jove M; Gatius S; Yeramian A; Portero-Otin M; Eritja N; Santacana M; Ruiz M; Pamplona R; Matias-Guiu X. |
Article d'investigació |
| Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: endometrial cancer as a model. |
2015 |
Eritja N, Santacana M, Maiques O, Gonzalez-Tallada X, Dolcet X, Matias-Guiu X: |
Article d'investigació |
| Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells |
2014 |
Eritja N, Domingo M, Dosil MA, Mirantes C, Santacana M, Valls J, Llombart-Cussac A, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas |
2014 |
Alonso-Alconada L, Eritja N, Muinelo-Romay L, Barbazan J, Lopez-Lopez R, Matias-Guiu X, Gil-Moreno A, Dolcet X, Abal M |
Article d'investigació |
| An inducible knock-out mouse to model cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias |
2013 |
Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X |
Article d'investigació |
| Three-dimensional epithelial cultures: a tool to model cancer development and progression |
2013 |
Eritja N, Dolcet X, Matias-Guiu X. |
Review |
| Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometriaT cells and drives PTEN loss-induced hyperplasic growth |
2013 |
Eritja, N.; Mirantes, C.; Llobet, D.; Yeramian, A.; Bergadà, L.; Dosil, M.A.; Domingo, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture |
2013 |
Chen N, Eritja N, Lock R, Debnath J. |
Article d'investigació |
| Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells |
2013 |
Bergadà, L.; Sorolla, A.; Yeramian, A.; Eritja, N.; Mirantes, C.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| ER alpha-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNF alpha and IL1 alpha in lumen formation and maintenance |
2012 |
Eritja N, Mirantes C, Llobet D, Masip G, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| Nuclear factor-kappa B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1 alpha independent manner |
2011 |
Yeramian, A.; Santacana, M.; Sorolla, A.; Llobet, D.; Encinas, M.; Velasco, A.; Bahi, N.; Eritja, N.; Domingo, M.; Oliva, E.; Dolcet, X.; Matias Guiu, X. |
Article d'investigació |
| KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. |
2011 |
Llobet, D.; Eritja, N.; Domingo, M.; Bergada, L.; Mirantes, C.; Santacana, M.; Pallares, J.; Macià, A.; Yeramian, A.; Encinas, M.; Moreno Bueno, G.; Palacios, J.; Lewis, R.E.; Matias Guiu, X.; Dolcet, |
Article d'investigació |
| The multikinase inhibitor sorafenib induces apoptosis and sensitizes endometrial cancer cells to TRAIL by different mechanisms |
2010 |
Llobet, D.; Eritja, N.; Encinas, M.; Yeramian, A.; Pallares, J.; Sorolla, A.; Santacana, M.; Gonzalez Tallada, F.J.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| A novel 3D culture system of polarized epithelial cells to study endometrial carcinogenesis |
2010 |
Eritja N; Llobet D; Domingo M; Yeramian A; Matias-Guiu X; Dolcet X. |
Article d'investigació |
| CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation. |
2009 |
Pallares J; Llobet D; Santacana M; Eritja N; Velasco A; Cuevas D; Lopez S; Palomar-Asenjo V; Yeramian A; Dolcet X; Matias-Guiu X. |
Article d'investigació |
| A review of the aplications of tissue microarray technology in understanding the molecular features of endometrial carcinoma |
2009 |
Pallarés J; Santacana M; Puente S; López S; Yeramian A; Eritja N; Sorolla A; Llobet D; Dolcet X; Matias-Guiu X |
Review |
| Molecular pathology of endometrial carcinoma; practical aspects from the diagnostic and therapeutical view points |
2009 |
Llobet D; Pallares J; Yeramian A; Santacana M; Eritja N; Velasco A; Dolcet X; Matias-Guiu X |
Review |
| Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma. |
2008 |
Pallarés J, Velasco A, Eritja N, Santacana M, Dolcet X, Cuatracasas M, Palomar-Asenjo V, Catasús Ll, Prat J, Matias-Guiu X. |
Article d'investigació |
| Nuclear factor-kappa B activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma |
2008 |
Gallel P; Pallares J; Dolcet X; Llobet D; Eritja N; Santacana M; Yeramian A; Palomar-Asenjo V; Lagarda H; Mauricio D; Encinas M; Matias-Guiu X |
Article d'investigació |
| Antioxidants block proteasome inhibitor function in endometrial carcinoma cells |
2008 |
Llobet D; Eritja N; Encinas M; Sorolla A; Yeramian A; Schoenenberger JA; Llombart-Cussac A; Martí RM; Matias-Guiu X; Dolcet X |
Article d'investigació |
| CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells |
2008 |
Llobet D; Eritja N; Encinas M; Llecha N; Yeramian A; Pallares J; Sorolla A; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X |
Article d'investigació |
| Loss of heterozygosity in endometrial carcinoma |
2008 |
Velasco A; Pallarés J; Santacana M; Yeramian A; Dolcet X; Eritja N; Puente S; Sorolla A; Llecha N; Matias-Guiu X |
Review |
